{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "CHF", "marketState": "REGULAR", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "esgPopulated": false, "regularMarketChangePercent": -2.076679, "regularMarketPrice": 0.613, "exchange": "EBS", "shortName": "SANTHERA N", "longName": "Santhera Pharmaceuticals Holding AG", "messageBoardId": "finmb_11609342", "exchangeTimezoneName": "Europe/Zurich", "market": "ch_market", "regularMarketTime": 1683880389, "regularMarketDayHigh": 0.627, "regularMarketDayRange": "0.62 - 0.627", "regularMarketDayLow": 0.62, "regularMarketVolume": 32740, "regularMarketPreviousClose": 0.626, "bid": 0.612, "ask": 0.625, "bidSize": 0, "askSize": 0, "fullExchangeName": "Swiss", "financialCurrency": "CHF", "regularMarketOpen": 0.627, "averageDailyVolume3Month": 338319, "averageDailyVolume10Day": 302586, "fiftyTwoWeekLowChange": 0.112999976, "fiftyTwoWeekLowChangePercent": 0.22599995, "fiftyTwoWeekRange": "0.5 - 2.03", "fiftyTwoWeekHighChange": -1.417, "fiftyTwoWeekHighChangePercent": -0.6980296, "fiftyTwoWeekLow": 0.5, "fiftyTwoWeekHigh": 2.03, "dividendDate": 1662595200, "earningsTimestamp": 1682598600, "earningsTimestampStart": 1682598600, "earningsTimestampEnd": 1682598600, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -1.21, "epsForward": -0.59, "sharesOutstanding": 61812900, "bookValue": -0.255, "fiftyDayAverage": 0.66158, "fiftyDayAverageChange": -0.04858005, "fiftyDayAverageChangePercent": -0.073430344, "twoHundredDayAverage": 0.74323, "twoHundredDayAverageChange": -0.13023001, "twoHundredDayAverageChangePercent": -0.17522168, "marketCap": 37891308, "forwardPE": -1.0389831, "priceToBook": -2.4039216, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "averageAnalystRating": "2.0 - Buy", "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1162540800000, "priceHint": 4, "regularMarketChange": -0.013000011, "symbol": "SANN.SW"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Hohenrainstrasse 24", "city": "Pratteln", "zip": "4133", "country": "Switzerland", "phone": "41 61 906 89 50", "fax": "41 61 906 89 51", "website": "https://www.santhera.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and commercializes medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the European Union and internationally. The company's lead pipeline candidate includes vamorolone, which is being developed as treatments for Duchenne muscular dystrophy (DMD). Its clinical stage pipeline also comprises lonodelestat (POL6014) to treat cystic fibrosis and other neutrophilic pulmonary diseases, as well as omigapil that treats congenital muscular dystrophies. The company also out-licenses outside North America and France rights to its approved product, Raxone (idebenone), for the treatment of Leber's hereditary optic neuropathy. Santhera Pharmaceuticals Holding AG was founded in 2004 and is headquartered in Pratteln, Switzerland.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Thomas  Meier Ph.D.", "age": 60, "title": "Founder & Chairman", "yearBorn": 1962, "fiscalYear": 2021, "totalPay": {"raw": 61250, "fmt": "61.25k", "longFmt": "61,250"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Dario  Eklund", "age": 54, "title": "Chief Exec. Officer", "yearBorn": 1968, "fiscalYear": 2021, "totalPay": {"raw": 715399, "fmt": "715.4k", "longFmt": "715,399"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Andrew P. Smith CGMA, FCMA", "age": 59, "title": "Chief Financial Officer", "yearBorn": 1963, "fiscalYear": 2020, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Marc  Schrader", "title": "Head of Technical Devel. & Operations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Eva  Kalias", "title": "Head of Investor Relations & Communications", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Oliver  Strub", "age": 59, "title": "Exec. VP, Gen. Counsel & Sec.", "yearBorn": 1963, "fiscalYear": 2020, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Neville  Kodkani M.D.", "title": "Head of Global Marketing & Partner Management", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Sarah  Holmes-Klotz", "title": "Head of People & Culture", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. G\u00fcnther  Metz Ph.D.", "age": 64, "title": "Head of Bus. Devel. & Exec. VP", "yearBorn": 1958, "fiscalYear": 2020, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Shabir  Hasham M.D.", "title": "Chief Medical Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1640908800, "maxAge": 86400}}], "error": null}}